There are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...

Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...

Indian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...

Indian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...

Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...

A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...

Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...

In an era of growing diplomatic relations, South American countries are increasingly turning to India, with Argentina leading the charge by...

Guwahati, Assam, is preparing to welcome a distinguished European Union delegation on June 8-9, as part of a mission to strengthen ties bet...

India targets $30 billion in seafood exports within five years. This ambitious goal involves increasing production and quality. The nation ...

Venezuela's acting President Delcy Eloina Rodriguez Gomez is in India for a five-day visit. She will meet Prime Minister Narendra Modi. The...

The latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...

Pharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...

Shares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece o...

Alkem Laboratories shares experienced significant block deals totaling Rs 930 crore. Promoter family entities divested shares to a group of...

Nine women now earn over one million dollars annually as C-suite executives. Domestic companies are leading this rise, reflecting a focus o...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...